HCM
Highline Capital Management Portfolio holdings
AUM
$51.6M
This Quarter Return
-17.82%
1 Year Return
-21.56%
3 Year Return
+183.68%
5 Year Return
+227.52%
10 Year Return
–
AUM
$1.49B
AUM Growth
+$1.49B
(-31%)
Cap. Flow
-$319M
Cap. Flow
% of AUM
-21.38%
Top 10 Holdings %
Top 10 Hldgs %
63.63%
Holding
47
New
15
Increased
9
Reduced
8
Closed
12
Top Buys
| 1 |
BERY
Berry Global Group, Inc.
BERY
|
$111M |
| 2 |
GRA
W.R. Grace & Co.
GRA
|
$108M |
| 3 |
Elevance Health
ELV
|
$88.8M |
| 4 |
MTOR
MERITOR, Inc.
MTOR
|
$39.4M |
| 5 |
I
INTELSAT S. A.
I
|
$32.3M |
Top Sells
| 1 |
TIF
Tiffany & Co.
TIF
|
$135M |
| 2 |
Bunge Global
BG
|
$110M |
| 3 |
Spotify
SPOT
|
$104M |
| 4 |
Intercontinental Exchange
ICE
|
$85.7M |
| 5 |
Amazon
AMZN
|
$85M |
Sector Composition
| 1 | Consumer Discretionary | 30.48% |
| 2 | Healthcare | 29.52% |
| 3 | Materials | 18.02% |
| 4 | Real Estate | 9.43% |
| 5 | Technology | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
IQVIA
IQV
$32.4B
| $115M | 7.68% | 986,131 -469,169 | -32% | -$54.5M |
|
|
BERY
2
DELISTED
Berry Global Group, Inc.
BERY
| $111M | 7.42% | +2,328,674 | New | +$111M |
|
|
GRA
3
DELISTED
W.R. Grace & Co.
GRA
| $108M | 7.27% | +1,670,400 | New | +$108M |
|
4
Royal Caribbean
RCL
$98.7B
| $106M | 7.07% | 1,078,950 +271,950 | +34% | +$26.6M |
|
5
Equinix
EQIX
$76.9B
| $101M | 6.75% | 285,615 -107,935 | -27% | -$38.1M |
|
|
6
Elevance Health
ELV
$71.8B
| $88.8M | 5.95% | +338,064 | New | +$88.8M |
|
7
BioMarin Pharmaceuticals
BMRN
$11.2B
| $86.3M | 5.78% | 1,013,119 -273,831 | -21% | -$23.3M |
|
8
Caesars Entertainment
CZR
$5.57B
| $82.8M | 5.55% | 2,287,099 -536,462 | -19% | -$19.4M |
|
9
ServiceNow
NOW
$190B
| $78.1M | 5.24% | 438,885 +8,885 | +2% | +$1.58M |
|
|
CZR
10
DELISTED
Caesars Entertainment Corporation
CZR
| $73.6M | 4.93% | 10,837,322 -1,835,612 | -14% | -$12.5M |
|
11
Commercial Metals
CMC
$6.46B
| $52.1M | 3.49% | 3,252,508 +671,091 | +26% | +$10.8M |
|
12
Boyd Gaming
BYD
$6.88B
| $45.1M | 3.02% | 2,170,939 -389,061 | -15% | -$8.08M |
|
13
VICI Properties
VICI
$36B
| $40M | 2.68% | 2,131,260 -123,740 | -5% | -$2.32M |
|
|
MTOR
14
DELISTED
MERITOR, Inc.
MTOR
| $39.4M | 2.64% | +2,330,180 | New | +$39.4M |
|
15
Pegasystems
PEGA
$9.27B
| $34.2M | 2.29% | 714,338 +260,338 | +57% | +$12.5M |
|
|
I
16
DELISTED
INTELSAT S. A.
I
| $32.3M | 2.16% | +1,509,683 | New | +$32.3M |
|
17
Rio Tinto
RIO
$102B
| $32.1M | 2.15% | +661,857 | New | +$32.1M |
|
18
Vale
VALE
$43.9B
| $26.6M | 1.78% | +2,017,848 | New | +$26.6M |
|
|
FPAC.U
19
DELISTED
Far Point Acquisition Corporation Units, each consisting of one share of Class A common stock, $0.00
FPAC.U
| $25.1M | 1.69% | 2,492,099 | – | – |
|
20
Regenxbio
RGNX
$451M
| $23.4M | 1.57% | 558,612 +216,612 | +63% | +$9.09M |
|
21
Moderna
MRNA
$9.37B
| $23.2M | 1.55% | +1,517,942 | New | +$23.2M |
|
22
ArcelorMittal
MT
$25.4B
| $23M | 1.54% | +1,113,695 | New | +$23M |
|
23
Ultragenyx Pharmaceutical
RARE
$2.89B
| $19.9M | 1.34% | 458,513 +30,393 | +7% | +$1.32M |
|
24
UroGen Pharma
URGN
$900M
| $19.9M | 1.33% | 461,678 +129,778 | +39% | +$5.59M |
|
25
Atara Biotherapeutics
ATRA
$84.6M
| $18M | 1.21% | 518,366 +290,966 | +128% | +$10.1M |
|